127 related articles for article (PubMed ID: 1347292)
1. A comparison of diagnostic criteria for neuroleptic malignant syndrome.
Gurrera RJ; Chang SS; Romero JA
J Clin Psychiatry; 1992 Feb; 53(2):56-62. PubMed ID: 1347292
[TBL] [Abstract][Full Text] [Related]
2. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
3. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
Lee JW
Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
[TBL] [Abstract][Full Text] [Related]
4. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic malignant syndrome: long-term follow-up of 20 cases.
Pope HG; Aizley HG; Keck PE; McElroy SL
J Clin Psychiatry; 1991 May; 52(5):208-12. PubMed ID: 1674508
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome in Mexico.
Montoya A; Ocampo M; Torres-Ruiz A
Can J Clin Pharmacol; 2003; 10(3):111-3. PubMed ID: 14506509
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death.
Tural U; Onder E
Psychiatry Clin Neurosci; 2010 Feb; 64(1):79-87. PubMed ID: 20416027
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
Sokoro AA; Zivot J; Ariano RE
Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
[TBL] [Abstract][Full Text] [Related]
10. [Studies of risk factors and preventive care for neuroleptic malignant syndrome].
Tanii H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):177-81. PubMed ID: 17240842
[TBL] [Abstract][Full Text] [Related]
11. Lithium and neuroleptics in combination: the spectrum of neurotoxicity [corrected].
Goldman SA
Psychopharmacol Bull; 1996; 32(3):299-309. PubMed ID: 8961772
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article.
Wait SD; Ponce FA; Killory BD; Wallace D; Rekate HL
J Neurosurg Pediatr; 2009 Sep; 4(3):217-21. PubMed ID: 19772404
[TBL] [Abstract][Full Text] [Related]
13. [Neuroleptic malignant syndrome. Case reports].
Berardi D; Troia M; Veronesi L; Ferrari G
Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
[TBL] [Abstract][Full Text] [Related]
14. [A study of neuroleptic malignant syndrome in the presenium and senium].
Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
[TBL] [Abstract][Full Text] [Related]
15. Patients with neuroleptic malignant syndrome histories: what happens when they are rehospitalized?
Gelenberg AJ; Bellinghausen B; Wojcik JD; Falk WE; Farhadi AM
J Clin Psychiatry; 1989 May; 50(5):178-80. PubMed ID: 2565897
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome: need for early diagnosis and therapy.
Khan HM; Syed NA; Sheerani M; Khcalani B; Kamal A; Wasay M
J Ayub Med Coll Abbottabad; 2006; 18(1):17-21. PubMed ID: 16773963
[TBL] [Abstract][Full Text] [Related]
17. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Borovicka MC; Bond LC; Gaughan KM
Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
[TBL] [Abstract][Full Text] [Related]
18. All elevated creatine kinase is not neuroleptic malignant syndrome.
Maniam T; Rahman MA
Med J Malaysia; 1994 Sep; 49(3):252-4. PubMed ID: 7845275
[TBL] [Abstract][Full Text] [Related]
19. [Malignant neuroleptic syndrome in patients with dementia].
Malling BJ
Ugeskr Laeger; 1999 Apr; 161(17):2541-2. PubMed ID: 10327877
[TBL] [Abstract][Full Text] [Related]
20. Clinical risk factors for neuroleptic malignant syndrome.
Berardi D; Dell'Atti M; Amore M; De Ronchi D; Ferrari G
Hum Psychopharmacol; 2002 Mar; 17(2):99-102. PubMed ID: 12404699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
